Trump Administration appears to have ended its US trade probe into pharmaceutical imports, according to End Point News

The Department of Commerce appears to have concluded its Section 232 investigation into Pharmaceutical imports, according to a new document reviewed by Endpoints News.

The termination of the trade probe into pharmaceutical imports signals a potential easing of trade tensions, which could reduce uncertainty for the sector and improve investor sentiment. This may provide some support for USD across FX markets, particularly against risk-sensitive currencies, while also positively impacting equities in the healthcare space. Traders should watch for any shifts in market sentiment, as this move could be seen as a stabilizing factor in U.S. trade relations.